With the increasing abuse of methylenedioxymethamphetamine (MDMA) thereby requiring analysis, we have undertaken a systematic evaluation on parameters associated with the analysis of MDMA and related compounds, including methylenedioxyamphetamine (MDA), methamphetamine (MA), and amphetamine (AM). Parameters studied included three solid-phase adsorbents, five derivatization reagents, and four deuterated internal standards (IS). This report examines whether differences in quantitation data derived from the use of four ISs (one for each analyte) and two ISs (one for AM and MA, one for MDA and MDMA) are statistically significant. Two types of samples were included in this study. The first type (Type I) included four replicate sets of standard solutions prepared in urine matrix. All analytes (AM, MA, MDA, and MDMA) were included in all samples, and these analytes' concentrations in each set were at five levels (100, 250, 500, 1000, and 2000 ng/mL). Four deuterated analogues (MA-ds, AM-ds, MDMA-ds, and MDA-d s) at 500 ng/mL were also included in all solutions. The second type of samples (Type II) included 25 case urine specimens. Most of these specimens contained MA/AM and/or MDMA/MDA. The specific objective of this study is to determine whether the 4-1S approach can indeed generate better quantitative data than a less-costly 2-IS. For Type I samples, where the true concentrations of the analytes are known, two-sample t-test is adapted to examine whether the two sets of prediction errors (i.e., known concentration minus calculated concentration) resulting from the 4-1S and the 2-1S approaches are statistically different. For Type II samples, where the analytes' true concentrations are unknown, one-sample t-test was adapted to determine whether the difference of the quantitation results derived from the 4-1S and the 2-1S approaches is statistically significant. Statistical analysis of quantitation data derived from Types I and II samples indicates that differences in MDA and 
Introduction
With the increase in the abuse of methylenemethamphetamine (MDMA, ecstasy) and the resultant analysis requirements, we have undertaken a systematic evaluation on parameters associated with the analysis of MDMA and related compounds, including methylenedioxyamphetamine (MDA), methamphetamine (MA), and amphetamine (AM). Parameters studied included liquid-liquid and solid-phase (three adsorbents) extraction, five derivatization groups, and four deuterated internal standards (ISs). This report examines whether differences in quantitation data derived from the use of four ISs (one for each analyte) and two ISs (one foraM and MA, one for MDA and MDMA) are statistically significant.
Internal standard method using isotopic analogues (mainly deuterated) of the analytes in conjunction with selected ion monitoring (SIM) gas chromatography-mass spectrometry (GC-MS) protocol are routinely used for quantitative analysis of drugs and their metabolites in biological matrices (1, 2) . For multi-component analysis, multiple ISs (one deuterated analogue for each analyte) are commonly adapted in the analytical protocol. In an earlier study (3) , in which pentobarbital-d~ was used as the sole IS using one-point calibration approach for the quantitation of four barbiturates (butabital, amobarbital, pentobarbital, and secobarbital), we have observed that quantitation results for pentobarbital were not necessarily better than those for the other analytes.
Simultaneous determinations of MDMA, MDA, MA, and AM are now commonly practiced (4) (5) (6) . With this in mind, we carried out a comprehensive study to determine whether quantitation results derived from a 4-IS approach (one deuterated analogue for each analyte) are indeed superior over a less costly 2-IS alternative (one for AM/MA and one for MDA/MDMA).
Materials and Methods
Type I (standard solutions) and Type II (case specimens) samples Two types of samples were included in this study. The first type included four replicate sets of standard solutions prepared in urine matrix. All analytes (AM, MA, MDA, and MDMA) were included in all samples, and these analytes' concentrations in each set were at five levels (100, 250, 500, 1000, and 2000 Derivatization. Five derivatization groups, 160 163 trimethylsilyl-, trichloroacetyl-, trifluoroacetyl-, pentafluoropropyl-, and heptafluo254w 261~ robutyl (HFB), were evaluated. A typical 210 213 derivatization protocol included the addition of 50 pL ethyl acetate into the dried residue of 206* 213 the extraction product, followed by the addi-211 tion of 75 pL heptafluorobutyric anhydride 209 (Aldrich, St. Louis, MO). The mixture was heated at 70~ for 20 min, then cooled to 50~ and dried under a stream of nitrogen. The residue was typically reconstituted with 100 pL ethyl acetate for GC-MS analysis. HP-5973N MSD (Agilent, Palo Alto, CA). A 30-m x 0.25-ram (0.25-pm film thickness) HP-1MS capillary column (Agilent, Little Falls, DE) was used for this study. The GC column was operated at an initial temperature of 100~ for 1 min, programmed to 300~ at 20~ with a l-rain hold at the final temperature. The injector and interface temperatures were 260~ and 280~ respectively.
GC-MS analysis. GC-MS analysis was performed on an HP-6890 GC interfaced to an
A two-step procedure (full-scan and SIM data collection) (7) was adapted to examine the extents of the intensities of ions designated for the analytes, but contributed by their respective ISs. Similarly, the intensities of ions designated for the ISs, but contributed by their respective analytes were also examined. Cross-contribution data derived from SIM studies were evaluated, and potentially usable ions are shown in Table I . Based on "intra-compound ion relative intensity" and "inter-compound (analyte and IS) ion cross-contribution" data, the HFB-derivatization and the following ions were selected for the quantita- Calibration. For the four-replicate sets of Type I samples, the SIM data collected from the first replicates (in five concentration levels) was used as the calibrators, based on which a linear calibration line was established. This calibration line was then used to derive the estimated concentration of each analyte in the remaining three sets of replicates. Parallel data were collected using the data collected from the second, the third, and the fourth set of the replicates as the calibrators.
Although each set of the replicates was used as the calibrators, each analyte's concentration was calculated using two different ISs. Thus, the concentrations of AM and MA were calculated using both AM-d8 and MA-d8 (separately) as the ISs. Similarly, the concentration of MDA and MDMA were calculated using both MDA-ds and MDMA-ds as the ISs. This protocol generated two pairs of concentration data for each analyte at each concentration level. Example data are graphically shown in Figure 1 .
Statistical analysis
For Type I samples, two-sample t-test (8) was adapted to examine whether the prediction errors (i.e., known concentration minus calculated concentration) resulting from the use of two ISs are statistically significant. Because the concentrations of the analytes in Type II samples are unknown, one-sample t-test (8) was adapted to determine whether the difference of the quantitation data derived from two ISs are statistically significant. Further details and results derived from these statistical analyses are presented in the next section.
Results and Discussion
The objective of this study is to determine whether multiple-IS approaches are necessarily more effective. Specifically, is the 4-IS approach (one IS for each analyte) can indeed generate Table V better quantitative data than a less costly 2-IS alternative (one IS for AM/MA and one IS for MDA/MDMA). To make this determination, differences in the concentrations of AM resulting from the use of two ISs (AM-d8 and MA-ds) are statistically examined. Similarly, evaluations are performed on the concentration differences of MA, MDA, and MDMA using AM-d8 and MA-ds, MDA-ds, and MDMA-d~, and MDA-ds and MDMA-ds, as the ISs, respectively. Statistical analysis applied to data derived from Type I and Type II samples are slightly different as described.
Type I samples (standard solutions)
Because the analytes' concentrations in Type I samples are known, statistical analysis of data derived from these samples focuses on the comparison of the prediction errors (i.e., known concentration minus calculated concentration) derived from the use of the two ISs under examination. Specifically, two-sample t-test is adapted to examine whether the two sets of log scale of square prediction errors resulting from two ISs the square of prediction errors ensures positive values for the log transformation, and the log transformed data are likely to be normally distributed and also allow for ratio comparisons. Statistical parameters resulting from the t-test are summarized in Table II . These statistical data indicate that, for AM and MA, the use of the analytes' respective deuterated analogues as the ISs appear to generate better quantitative data. On the other hand, for MDA and MDMA, there are nonsignificant differences in quantitative data resulting from the use of MDAd5 and from the use of MDMA-d5 (Table III) .
Type II samples (case specimens)
The 25 case specimens included in this study were analyzed using both liquid-liquid and solid-phase (Isolute) extraction protocols. Analyte concentrations derived from the use of two ISs are summarized and compared in Table IV . Inadequate number of AM/MA data were available and not examined further.
Because the true concentrations of MDMA and MDA in these case specimens are unknown, prediction errors are not available. Instead, we focus on the comparison of predicted concentrations, that is, ratio of predicted concentrations using MDMA-d5 as IS versus predicted concentrations using MDA-d5 as IS. We use one-sample t-test to analyze the log scale of the ratio to determine whether the difference of the quantitation results derived from two ISs are statisticaIly significant. The log transformation is to ensure that data are normally distributed, which is required by the t-test. Resulting statistical data in Table V indicate there is nonsignificant difference between the use of MDA-d5 as IS and the use of MDMA-d5 as IS to predict MDMA (and MDA) concentrations.
Conclusions
Statistical analysis of quantitation data derived from four replicate sets of standard solutions and 25 case specimens indicates that the use of MDA-d5 as IS and the use of MDMA-d5 as IS give similar results for prediction of MDMA (and MDA) concentrations. On the other hand, similar analysis on data derived from four replicate sets of standard solutions indicate the use of the analytes' respective deuterated analogues as the ISs appear to generate better quantitative data for AM and ]vIA.
